The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Rose geranium in sesame oil nasal spray to improve symptoms of nasal vestibulitis: A phase III double blinded randomized controlled trial.
 
Elizabeth Jane Cathcart-Rake
No Relationships to Disclose
 
Paul J. Novotny
Stock and Other Ownership Interests - United Health Group
 
Deanne R. Smith
No Relationships to Disclose
 
Susan E. Lewis-Peters
No Relationships to Disclose
 
Karthik Giridhar
Consulting or Advisory Role - AstraZeneca/Daiichi Sankyo (Inst); Gilead Sciences (Inst); Novartis (Inst); Puma Biotechnology (Inst); Tersera (Inst)
Research Funding - Pfizer (Inst)
 
Kimberly O. Steinert
No Relationships to Disclose
 
Darcie Dauer
No Relationships to Disclose
 
Amanda K. O'Connor
No Relationships to Disclose
 
Stephan Thome
No Relationships to Disclose
 
Terra A. Register
No Relationships to Disclose
 
Marsha K. Erickson
No Relationships to Disclose
 
Bret Edward Buckley Friday
No Relationships to Disclose
 
Charles L. Loprinzi
Consulting or Advisory Role - Bexion; Denali Therapeutics; Disarm Therapeutics; Grunenthal; Hengrui Pharmaceutical; Metys Pharmaceuticals; Metys Pharmaceuticals; Mitsubishi Tanabe Pharma; Neuropathix; NKMax; OnQuality Pharmaceuticals; Osmol Therapeutics; Veloxis
Research Funding - Bristol-Myers Squibb (Inst)